Diagnostic accuracy of molecular methods for detecting markers of antimalarial drug resistance in clinical samples of Plasmodium falciparum: protocol for an update to a systematic review and meta-analysis

Diagnostic accuracy of molecular methods for detecting markers of antimalarial drug resistance in clinical samples of Plasmodium falciparum: protocol for an update to a systematic review and meta-analysis

<strong>Background</strong> Each year, infection with Plasmodium causes millions of clinical cases of malaria and hundreds of thousands of deaths. Resistance to different antimalarial medications continues to develop and spread, threatening effective prophylaxis and treatment. Surveillan...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Burrow, R, Fanshawe, T, Humphreys, G
Format:	Journal article
Język:	English
Wydane:	BioMed Central 2018

Podobne zapisy

Diagnostic accuracy of molecular methods for detecting markers of antimalarial drug resistance in clinical samples of Plasmodium falciparum: protocol for an update to a systematic review and meta-analysis
od: Rebekah Burrow, i wsp.
Wydane: (2018-12-01)

Sensitivity and specificity of molecular methods for detecting markers of antimalarial drug resistance in clinical samples of Plasmodium falciparum: a systematic review
od: Burrow, R
Wydane: (2017)

Effects of antimalarial drugs on movement of Plasmodium falciparum.
od: Wongtanachai, J, i wsp.
Wydane: (2012)

Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
od: Barnes, K, i wsp.
Wydane: (2005)

Antimalarial drugs reduce cytoadherence and rosetting Plasmodium falciparum.
od: Udomsangpetch, R, i wsp.
Wydane: (1996)

Putative molecular markers of Plasmodium falciparum resistance to antimalarial drugs in malaria parasites from Ghana
od: Sena Adzoa Matrevi, i wsp.
Wydane: (2024-02-01)

Molecular epidemiology of Plasmodium falciparum resistance to antimalarial drugs in Indonesia.
od: Syafruddin, D, i wsp.
Wydane: (2005)

Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline
od: Oriana Kreutzfeld, i wsp.
Wydane: (2023-06-01)

Assessment of Markers of Antimalarial Drug Resistance in Plasmodium falciparum Isolates from Pregnant Women in Lagos, Nigeria.
od: Chimere Obiora Agomo, i wsp.
Wydane: (2016-01-01)

Surveillance of molecular markers of antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Federally Administered Tribal Area (FATA), Pakistan
od: Muhammad Faisal Nadeem, i wsp.
Wydane: (2021-07-01)

Validation of Plasmodium falciparum deoxyhypusine synthase as an antimalarial target
od: Aiyada Aroonsri, i wsp.
Wydane: (2019-04-01)

Targeting the Plasmodium falciparum proteome and organelles for potential antimalarial drug candidates
od: James Abugri, i wsp.
Wydane: (2022-08-01)

Genomic Epidemiology of Antimalarial Drug Resistance in Plasmodium falciparum in Southern China
od: Fang Huang, i wsp.
Wydane: (2021-01-01)

Prospective surveillance study to detect antimalarial drug resistance, gene deletions of diagnostic relevance and genetic diversity of Plasmodium falciparum in Mozambique: protocol
od: Alexandra Wharton-Smith, i wsp.
Wydane: (2022-07-01)

The effect of dose on the antimalarial efficacy of artesunate-mefloquine against Plasmodium falciparum malaria: a protocol for systematic review and individual patient data (IPD) meta-analysis
od: Mansoor, R, i wsp.
Wydane: (2019)

In vitro susceptibility profile of Plasmodium falciparum clinical isolates from Ghana to antimalarial drugs and polymorphisms in resistance markers
od: Wei Zhao, i wsp.
Wydane: (2022-10-01)

Targeted deep amplicon sequencing of antimalarial resistance markers in Plasmodium falciparum isolates from Cameroon
od: Mariangela L’Episcopia, i wsp.
Wydane: (2021-06-01)

Serine Proteases of Malaria Parasite Plasmodium falciparum: Potential as Antimalarial Drug Targets
od: Asrar Alam
Wydane: (2014-01-01)

Epidemic of Plasmodium falciparum Malaria Involving Substandard Antimalarial Drugs, Pakistan, 2003
od: Toby Leslie, i wsp.
Wydane: (2009-11-01)

Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
od: Wang, LT
Wydane: (2022)

Antimalarial target vulnerability of the putative Plasmodium falciparum methionine synthase
od: Nirut Leela, i wsp.
Wydane: (2024-01-01)

The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC
od: Robert Verity, i wsp.
Wydane: (2020-04-01)

Molecular Profiles of Multiple Antimalarial Drug Resistance Markers in <i>Plasmodium falciparum</i> and <i>Plasmodium vivax</i> in the Mandalay Region, Myanmar
od: Hương Giang Lê, i wsp.
Wydane: (2022-10-01)

Prevalence of Plasmodium falciparum molecular markers of antimalarial drug resistance in a residual malaria focus area in Sabah, Malaysia
od: Norahmad, NA, i wsp.
Wydane: (2016)

Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon
od: Peter Thelma Ngwa Niba, i wsp.
Wydane: (2023-07-01)

Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs.
od: Delves, M, i wsp.
Wydane: (2013)

Effect of membrane filtration of antimalarial drug solutions on in vitro activity against Plasmodium falciparum.
od: Baird, J, i wsp.
Wydane: (1984)

Plasmodium falciparum protein kinase as a potential therapeutic target for antimalarial drugs development
od: Fauze Mahmud, i wsp.
Wydane: (2020)

Antimalarial Drug Predictions Using Molecular Descriptors and Machine Learning against Plasmodium Falciparum
od: Medard Edmund Mswahili, i wsp.
Wydane: (2021-11-01)

Antimalarial drug susceptibility testing of Plasmodium falciparum in Brazil using a radioisotope method
od: Crispim Cerutti Junior, i wsp.
Wydane: (1999-11-01)

Structural model of the Plasmodium falciparum Thioredoxin reductase:a novel target for antimalarial drugs
od: Amit Kumar Banerjee, i wsp.
Wydane: (2009-09-01)

Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use.
od: Nitchakarn Noranate, i wsp.
Wydane: (2007-01-01)

<it>In-vitro</it> studies on the sensitivity pattern of <it>Plasmodium falciparum</it> to antimalarial drugs and local herbal extracts
od: Olasehinde Grace, i wsp.
Wydane: (2012-10-01)

Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana
od: Yaw Aniweh, i wsp.
Wydane: (2023-06-01)

Prevalence and temporal changes of mutations linked to antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Palawan, Philippines
od: Alison Paolo N. Bareng, i wsp.
Wydane: (2022-03-01)

Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
od: Lim, P, i wsp.
Wydane: (2013)

Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia.
od: Baird, J, i wsp.
Wydane: (1991)

The Heterogenity Of Response Of Different Strains And Clones of plasmodium Falciparum to antimalarials in vitro
od: Perpustakaan UGM, i-lib
Wydane: (1989)

The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria.
od: Chotivanich, K, i wsp.
Wydane: (2000)

The mechanism of antimalarial action of ellagic acid on haemoglobin metabolism in plasmodium falciparum
od: Thuduhena, Thuduhenage Dona Anjana Chamilka
Wydane: (2024)